# FDA Inspection 1236122 - K2M, Inc. - March 21, 2024

Source: https://www.globalkeysolutions.net/records/fda_inspections/k2m-inc/f68d2bb0-b6ae-427f-bad7-c45a44794b12/
Source feed: FDA_Inspections

> FDA Inspection 1236122 for K2M, Inc. on March 21, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1236122
- Company Name: K2M, Inc.
- Inspection Date: 2024-03-21
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1236122 - 2024-03-21](https://www.globalkeysolutions.net/api/records/fda_inspections/k2m-inc/1491f2aa-dc22-4c8a-8da9-9416a1017c6a/)
- [FDA Inspection 1168720 - 2022-04-21](https://www.globalkeysolutions.net/api/records/fda_inspections/k2m-inc/20052a4b-17f4-4a55-a964-c1a53562e75d/)
- [FDA Inspection 1168720 - 2022-04-21](https://www.globalkeysolutions.net/api/records/fda_inspections/k2m-inc/f906299b-b489-43e7-b08f-c5e5a1ecb771/)
- [FDA Inspection 1148726 - 2021-07-27](https://www.globalkeysolutions.net/api/records/fda_inspections/k2m-inc/c9dfbd98-0f6b-4549-b1be-6317a8fe2920/)
- [FDA Inspection 1148726 - 2021-07-27](https://www.globalkeysolutions.net/api/records/fda_inspections/k2m-inc/454d4a18-9f02-4c82-928b-a4a8335a65a1/)

Company: https://www.globalkeysolutions.net/companies/k2m-inc/03b0edf1-8ffe-422a-8877-c7bff00baa05

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d